KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Gains from Sales and Divestitures (2021 - 2023)

Historic Gains from Sales and Divestitures for Ginkgo Bioworks Holdings (DNA) over the last 3 years, with Q2 2023 value amounting to $27.2 million.

  • Ginkgo Bioworks Holdings' Gains from Sales and Divestitures rose 7490.95% to $27.2 million in Q2 2023 from the same period last year, while for Jun 2023 it was $27.2 million, marking a year-over-year increase of 7490.95%. This contributed to the annual value of $136.2 million for FY2022, which is 5866.69% up from last year.
  • According to the latest figures from Q2 2023, Ginkgo Bioworks Holdings' Gains from Sales and Divestitures is $27.2 million, which was up 7490.95% from $11.8 million recorded in Q1 2023.
  • In the past 5 years, Ginkgo Bioworks Holdings' Gains from Sales and Divestitures ranged from a high of $136.2 million in Q4 2022 and a low of $7.5 million during Q1 2022
  • In the last 3 years, Ginkgo Bioworks Holdings' Gains from Sales and Divestitures had a median value of $23.5 million in 2022 and averaged $43.9 million.
  • The largest annual percentage gain for Ginkgo Bioworks Holdings' Gains from Sales and Divestitures in the last 5 years was 7490.95% (2023), contrasted with its biggest fall of 5830.76% (2023).
  • Quarter analysis of 3 years shows Ginkgo Bioworks Holdings' Gains from Sales and Divestitures stood at $85.8 million in 2021, then soared by 58.67% to $136.2 million in 2022, then tumbled by 80.01% to $27.2 million in 2023.
  • Its Gains from Sales and Divestitures was $27.2 million in Q2 2023, compared to $11.8 million in Q1 2023 and $136.2 million in Q4 2022.